IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2016. The put-call ratio across all filers is 269.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $5,000 | -16.7% | 272 | 0.0% | 0.00% | – |
| Q3 2017 | $6,000 | +50.0% | 272 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | -99.7% | 272 | -99.8% | 0.00% | -100.0% |
| Q1 2017 | $1,497,000 | -4.5% | 118,327 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $1,568,000 | -61.6% | 118,327 | -31.3% | 0.01% | -59.4% |
| Q3 2016 | $4,082,000 | -16.7% | 172,237 | +1.3% | 0.03% | -23.8% |
| Q2 2016 | $4,901,000 | -10.0% | 170,057 | 0.0% | 0.04% | -19.2% |
| Q1 2016 | $5,445,000 | -28.3% | 170,057 | -4.2% | 0.05% | -28.8% |
| Q4 2015 | $7,589,000 | +17.6% | 177,473 | -3.2% | 0.07% | +7.4% |
| Q3 2015 | $6,452,000 | -23.7% | 183,256 | -0.5% | 0.07% | -34.6% |
| Q2 2015 | $8,461,000 | -2.0% | 184,265 | 0.0% | 0.10% | +6.1% |
| Q1 2015 | $8,636,000 | +35.4% | 184,265 | -8.4% | 0.10% | +34.2% |
| Q4 2014 | $6,376,000 | – | 201,240 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |